Tuesday, November 2, 2021

Calquence shows long-term efficacy and tolerability in MCL




Patients with relapsed or refractory mantle cell lymphoma (MCL) treated with AstraZeneca’s Calquence (acalabrutinib) remained progression free for a median of 22 months, with median overall survival not yet reached at three years of follow-up, according to long-term follow-up data from the ACE-LY-004 Phase II trial.

At a median follow up of 38.1 months, 55 patients (44%) either remained on treatment (24 patients) or continued to be followed for survival (31 patients).

The results, presented at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, also showed a consistent safety and tolerability profile for the drug in this setting, with with only 14 patients (11%) having discontinued treatment due to adverse events.

“Mantle cell lymphoma is an aggressive, difficult-to-treat blood cancer that is typically diagnosed at an advanced stage and often becomes resistant to treatment. This data shows that patients treated with acalabrutinib experienced deep responses over time, while the safety profile remained largely the same, including low rates of Grade 3/4 events, cardiac events and bleeding events, which are important in this patient population,” said Michael Wang, Professor, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, and principal investigator of the trial, commenting on the findings.

The findings “add to the mounting evidence that Calquence can provide sustained responses in patients over more than three years,” added José Baselga, executive vice president, Oncology R&D at AZ. “Calquence is an important chemo-free treatment option for relapsed or refractory mantle cell lymphoma and is rapidly being embraced across the clinical and patient community.”

MCL is typically an aggressive, rare form of non-Hodgkin lymphoma (NHL) that accounts for nearly 6% of all NHL cases, and is mostly diagnosed in men during their early sixties.



Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...